Carson Wealth (CWM LLC)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $469K | Buy |
15,579
+8,117
| +109% | +$261K | ﹤0.01% | 2065 |
|
|
2025
Q4 | $233K | Buy |
7,462
+2,101
| +39% | +$51.8K | ﹤0.01% | 2449 |
|
|
2025
Q3 | $108K | Buy |
5,361
+366
| +7% | +$6.43K | ﹤0.01% | 2926 |
|
|
2025
Q2 | $84K | Buy |
4,995
+767
| +18% | +$12.4K | ﹤0.01% | 2871 |
|
|
2025
Q1 | $65K | Buy |
4,228
+148
| +4% | +$2.64K | ﹤0.01% | 2756 |
|
|
2024
Q4 | $90K | Sell |
4,080
-112
| -3% | -$2.04K | ﹤0.01% | 2357 |
|
|
2024
Q3 | $76K | Buy |
4,192
+126
| +3% | +$2.21K | ﹤0.01% | 2373 |
|
|
2024
Q2 | $66K | Buy |
4,066
+395
| +11% | +$6.08K | ﹤0.01% | 2274 |
|
|
2024
Q1 | $52K | Buy |
3,671
+420
| +13% | +$5.29K | ﹤0.01% | 2278 |
|
|
2023
Q4 | $34K | Buy |
3,251
+362
| +13% | +$3.38K | ﹤0.01% | 2423 |
|
|
2023
Q3 | $29K | Buy |
2,889
+896
| +45% | +$8.34K | ﹤0.01% | 2434 |
|
|
2023
Q2 | $15K | Sell |
1,993
-95
| -5% | -$770 | ﹤0.01% | 2840 |
|
|
2023
Q1 | $18K | Sell |
2,088
-102
| -5% | -$1.01K | ﹤0.01% | 2589 |
|
|
2022
Q4 | $20K | Buy |
2,190
+163
| +8% | +$1.42K | ﹤0.01% | 2385 |
|
|
2022
Q3 | $16K | Buy |
2,027
+204
| +11% | +$1.8K | ﹤0.01% | 2396 |
|
|
2022
Q2 | $14K | Buy |
1,823
+200
| +12% | +$1.74K | ﹤0.01% | 2387 |
|
|
2022
Q1 | $15K | Sell |
1,623
-147
| -8% | -$1.23K | ﹤0.01% | 2265 |
|
|
2021
Q4 | $14K | Buy |
+1,770
| New | +$16K | ﹤0.01% | 2183 |
|
|
2021
Q2 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2075 |
|
|
2021
Q1 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2074 |
|
|
2020
Q4 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2073 |
|
|
2020
Q3 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2072 |
|
|
2020
Q2 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2071 |
|
|
2020
Q1 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2071 |
|
|
2019
Q4 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2071 |
|
|
2019
Q3 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2071 |
|
|
2019
Q2 | $11K | Hold |
1,105
| – | – | ﹤0.01% | 2071 |
|
|
2019
Q1 | $11K | Sell |
1,105
-6,433
| -85% | -$113K | ﹤0.01% | 2071 |
|
|
2018
Q4 | $116K | Buy |
7,538
+1,236
| +20% | +$25.3K | ﹤0.01% | 698 |
|
|
2018
Q3 | $136K | Buy |
6,302
+6,300
| +315,000% | +$146K | ﹤0.01% | 577 |
|
|
2018
Q2 | $0 | Sell |
2
-63
| -97% | -$1.28K | ﹤0.01% | 1776 |
|
|
2018
Q1 | $1K | Sell |
65
-2
| -3% | -$39 | ﹤0.01% | 1333 |
|
|
2017
Q4 | $1K | Sell |
67
-300
| -82% | -$4.51K | ﹤0.01% | 1399 |
|
|
2017
Q3 | $6K | Sell |
367
-4,244
| -92% | -$95.5K | ﹤0.01% | 1041 |
|
|
2017
Q2 | $153K | Sell |
4,611
-1,400
| -23% | -$43.3K | 0.01% | 338 |
|
|
2017
Q1 | $193K | Sell |
6,011
-58,050
| -91% | -$1.98M | 0.01% | 294 |
|
|
2016
Q4 | $2.32M | Buy |
64,061
+652
| +1% | +$26K | 0.14% | 140 |
|
|
2016
Q3 | $2.92M | Buy |
63,409
+24,400
| +63% | +$1.27M | 0.2% | 125 |
|
|
2016
Q2 | $1.96M | Buy |
+39,009
| New | +$2.08M | 0.14% | 154 |
|
|
2016
Q1 | – | Sell |
-136
| Closed | -$9K | – | 812 |
|
|
2015
Q4 | $9K | Sell |
136
-79
| -37% | -$4.88K | ﹤0.01% | 480 |
|
|
2015
Q3 | $12K | Buy |
+215
| New | +$13.9K | ﹤0.01% | 432 |
|
Other funds holding TEVA
HIIFS
PF
MMH
CI
MIFH
LIM
Carson Wealth (CWM LLC)'s TEVA Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Teva Pharmaceuticals (TEVA) stake by 109% in Q1 2026, buying an estimated $261K and bringing the position to 15,579 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.
Carson Wealth (CWM LLC) first reported a position in TEVA in Q3 2015 and has held it in 41 quarters since. The position peaked at $2.92M in Q3 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.
- Carson Wealth (CWM LLC) held 15,579 shares of Teva Pharmaceuticals worth $469K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 8,117 Teva Pharmaceuticals shares in Q1 2026, an estimated $261K.
- Teva Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2065 holding.
- Carson Wealth (CWM LLC) first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 41 quarters since.
- Carson Wealth (CWM LLC)'s Teva Pharmaceuticals position peaked at $2.92M in Q3 2016.
- 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.